技术优势：为何DEFND-seq是游戏规则改变者？ “一站式”分析平台：无需改造设备，直接兼容10x Genomics商业化系统，全球实验室可快速部署。 冷冻 ...

Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...

PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...

10x Genomics, Inc. (NASDAQ:TXG – Free Report) – Analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of 10x Genomics in a research note issued to investors on ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

引言在肿瘤的微观宇宙中，每个癌细胞都像是携带双重身份的特工：它的DNA中潜藏着驱动恶性行为的突变密码，而RNA则实时演绎着这些指令带来的致命行动。然而，研究人员长久以来被迫以“分屏视角”观察这场阴谋——单细胞RNA测序（scRNA-seq）揭示细胞的行为特征，单细胞DNA测序（scDNA-seq）捕捉基因组的异常，但二者如同断线 ...

2025 年 2 月 19 日,北京时间 ,律商联讯 ( LexisNexis® Legal & Professional )发布了 2025 年 “全球创新百强 ...